振德医疗：预计公司非洲生产基地本年末扭亏为盈，并积极推进墨西哥生产基地建设

Core Viewpoint - The company is focusing on expanding its overseas production bases and enhancing strategic partnerships with international clients to meet the diversified supply chain demands in the current market environment [1] Group 1: Overseas Market Strategy - The company plans to continue the construction, production, and operation of overseas production bases to leverage its global supply chain advantages [1] - There is an emphasis on strengthening strategic cooperation with international clients, particularly core major clients, to capture more business opportunities and market share [1] Group 2: Emerging Market Focus - The company aims to address the rapidly increasing demand for basic medical consumables in emerging markets, particularly in Southeast Asia, North America, and South America [1] - The company will enhance its investment in these regions, utilizing its product portfolio, quality control, and cost management advantages to increase global market coverage and penetration [1] Group 3: Operational Efficiency - The company's African production base, which commenced operations in the second half of last year, is expected to achieve profitability by the end of this year [1] - The company is also actively advancing the construction of its production base in Mexico [1]